NCR3 and psoriasis: CD161 serves as a marker for NK cells that can respond to IL-12 and IL-18 during differentiation, leading to the subsequent upregulation of NKp30, CD160, CD25, CD69, and IFN-γ—an identified psoriasis-associated pathogenic factor (82).